-
1
-
-
0020533055
-
Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor
-
Dolittle R.F., Hunkapiller M.W., Hood L.E., Devare S.G., Robbins K.C., Aaronson S.A., et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 221:1983;275-277
-
(1983)
Science
, vol.221
, pp. 275-277
-
-
Dolittle, R.F.1
Hunkapiller, M.W.2
Hood, L.E.3
Devare, S.G.4
Robbins, K.C.5
Aaronson, S.A.6
-
3
-
-
0021266088
-
Transformation of NIH 3T3 cells by a human c-sis cDNA clone
-
Clarke M.F., Westin E., Schmidt D., Josephs S.F., Ratner L., Wong-Staal F., et al. Transformation of NIH 3T3 cells by a human c-sis cDNA clone. Nature. 308:1984;464-467
-
(1984)
Nature
, vol.308
, pp. 464-467
-
-
Clarke, M.F.1
Westin, E.2
Schmidt, D.3
Josephs, S.F.4
Ratner, L.5
Wong-Staal, F.6
-
4
-
-
0021703127
-
Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation
-
Gazit A., Igarashi H., Chiu I.-M., Srinivasan A., Yaniv A., Tronick S.R., et al. Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell. 39:1984;89-97
-
(1984)
Cell
, vol.39
, pp. 89-97
-
-
Gazit, A.1
Igarashi, H.2
Chiu, I.-M.3
Srinivasan, A.4
Yaniv, A.5
Tronick, S.R.6
-
5
-
-
0021364016
-
Human proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus
-
Josephs S.F., Guo C., Ratner L., Wong-Staal F. Human proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus. Science. 223:1984;487-491
-
(1984)
Science
, vol.223
, pp. 487-491
-
-
Josephs, S.F.1
Guo, C.2
Ratner, L.3
Wong-Staal, F.4
-
6
-
-
0023722311
-
Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains
-
Beckmann M.P., Betsholtz C., Heldin C.-H., Westermark B., Di Marco E., Di Fiore P.P., et al. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science. 241:1988;1346-1349
-
(1988)
Science
, vol.241
, pp. 1346-1349
-
-
Beckmann, M.P.1
Betsholtz, C.2
Heldin, C.-H.3
Westermark, B.4
Di Marco, E.5
Di Fiore, P.P.6
-
7
-
-
0023916425
-
Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in Rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects
-
Bywater M., Rorsman F., Bongcam-Rudloff E., Mark G., Hammacher A., Heldin C.-H., et al. Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in Rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects. Mol. Cell. Biol. 8:1988;2753-2762
-
(1988)
Mol. Cell. Biol.
, vol.8
, pp. 2753-2762
-
-
Bywater, M.1
Rorsman, F.2
Bongcam-Rudloff, E.3
Mark, G.4
Hammacher, A.5
Heldin, C.-H.6
-
8
-
-
0037434985
-
PDGF-D is a potent transforming and angiogenic growth factor
-
Li H., Fredriksson L., Li X., Eriksson U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene. 22:2003;1501-1510
-
(2003)
Oncogene
, vol.22
, pp. 1501-1510
-
-
Li, H.1
Fredriksson, L.2
Li, X.3
Eriksson, U.4
-
9
-
-
0037402488
-
Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment
-
Sirvent N., Maire G., Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer. 37:2003;1-19
-
(2003)
Genes Chromosomes Cancer
, vol.37
, pp. 1-19
-
-
Sirvent, N.1
Maire, G.2
Pedeutour, F.3
-
10
-
-
0031012850
-
Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma
-
Simon M.-P., Pedeutour F., Sirvent N., Grosgeorge J., Minoletti F., Coindre J.-M., et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet. 15:1997;95-98
-
(1997)
Nat. Genet.
, vol.15
, pp. 95-98
-
-
Simon, M.-P.1
Pedeutour, F.2
Sirvent, N.3
Grosgeorge, J.4
Minoletti, F.5
Coindre, J.-M.6
-
11
-
-
0033178762
-
The dermatofibrosarcoma protuberans-associated collagen type Iα1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB
-
Shimizu A., O'Brien K.P., Sjöblom T., Pietras K., Buchdunger E., Collins V.P., et al. The dermatofibrosarcoma protuberans-associated collagen type Iα1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 59:1999;3719-3723
-
(1999)
Cancer Res.
, vol.59
, pp. 3719-3723
-
-
Shimizu, A.1
O'Brien, K.P.2
Sjöblom, T.3
Pietras, K.4
Buchdunger, E.5
Collins, V.P.6
-
12
-
-
0035942502
-
Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in dermatofibrosarcoma protuberans (DP)
-
Simon M.-P., Navarro M., Roux D., Pouysségur J. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in dermatofibrosarcoma protuberans (DP). Oncogene. 20:2001;2965-2975
-
(2001)
Oncogene
, vol.20
, pp. 2965-2975
-
-
Simon, M.-P.1
Navarro, M.2
Roux, D.3
Pouysségur, J.4
-
13
-
-
0032505090
-
Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans
-
Greco A., Fusetti L., Villa R., Sozzi G., Minoletti F., Mauri P., et al. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans. Oncogene. 17:1998;1313-1319
-
(1998)
Oncogene
, vol.17
, pp. 1313-1319
-
-
Greco, A.1
Fusetti, L.2
Villa, R.3
Sozzi, G.4
Minoletti, F.5
Mauri, P.6
-
14
-
-
0035421175
-
Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis
-
Sjöblom T., Shimizu A., O'Brien K.P., Pietras K., Dal Cin P., Buchdunger E., et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res. 61:2001;5778-5783
-
(2001)
Cancer Res.
, vol.61
, pp. 5778-5783
-
-
Sjöblom, T.1
Shimizu, A.2
O'Brien, K.P.3
Pietras, K.4
Dal Cin, P.5
Buchdunger, E.6
-
15
-
-
0036846345
-
Management of malignant gastrointestinal stromal tumours
-
Joensuu H., Fletcher C., Dimitrijevic S., Silberman S., Roberts P., Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 3:2002;655-664
-
(2002)
Lancet Oncol.
, vol.3
, pp. 655-664
-
-
Joensuu, H.1
Fletcher, C.2
Dimitrijevic, S.3
Silberman, S.4
Roberts, P.5
Demetri, G.6
-
16
-
-
0031947592
-
Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
-
Kindblom L.G., Remotti H.E., Aldenborg F., Meis-Kindblom J.M. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 152:1998;1259-1269
-
(1998)
Am. J. Pathol.
, vol.152
, pp. 1259-1269
-
-
Kindblom, L.G.1
Remotti, H.E.2
Aldenborg, F.3
Meis-Kindblom, J.M.4
-
17
-
-
0037087531
-
Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies
-
Heinrich M.C., Blanke C.D., Druker B.J., Corless C.L. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J. Clin. Oncol. 20:2002;1692-1703
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 1692-1703
-
-
Heinrich, M.C.1
Blanke, C.D.2
Druker, B.J.3
Corless, C.L.4
-
18
-
-
0242670019
-
PDGFRA activating mutations in gastrointestinal stromal tumors
-
Heinrich M.C., Corless C.L., Duensing A., McGreevey L., Chen C.J., Joseph N., et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 299:2003;708-710
-
(2003)
Science
, vol.299
, pp. 708-710
-
-
Heinrich, M.C.1
Corless, C.L.2
Duensing, A.3
McGreevey, L.4
Chen, C.J.5
Joseph, N.6
-
19
-
-
0041971080
-
Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors
-
Hirota S., Ohashi A., Nishida T., Isozaki K., Kinoshita K., Shinomura Y., et al. Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors. Gastroenterology. 125:2003;660-667
-
(2003)
Gastroenterology
, vol.125
, pp. 660-667
-
-
Hirota, S.1
Ohashi, A.2
Nishida, T.3
Isozaki, K.4
Kinoshita, K.5
Shinomura, Y.6
-
20
-
-
0642368571
-
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
-
Heinrich M.C., Corless C.L., Demetri G.D., Blanke C.D., von Mehren M., Joensuu H., et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J. Clin. Oncol. 21:2003;4342-4349
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 4342-4349
-
-
Heinrich, M.C.1
Corless, C.L.2
Demetri, G.D.3
Blanke, C.D.4
Von Mehren, M.5
Joensuu, H.6
-
21
-
-
0036045381
-
Tyrosine kinase fusion genes in chronic myeloproliferative diseases
-
Cross N.C., Reiter A. Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia. 16:2002;1207-1212
-
(2002)
Leukemia
, vol.16
, pp. 1207-1212
-
-
Cross, N.C.1
Reiter, A.2
-
22
-
-
0036202529
-
Myeloproliferative disorders with translocations of chromosome 5q31-35: Role of the platelet-derived growth factor receptor beta
-
Steer E.J., Cross N.C. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor beta. Acta Haematol. 107:2002;113-122
-
(2002)
Acta Haematol.
, vol.107
, pp. 113-122
-
-
Steer, E.J.1
Cross, N.C.2
-
23
-
-
0028224348
-
Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
-
Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77:1994;307-316
-
(1994)
Cell
, vol.77
, pp. 307-316
-
-
Golub, T.R.1
Barker, G.F.2
Lovett, M.3
Gilliland, D.G.4
-
24
-
-
0029966854
-
The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways
-
Carroll M., Tomasson M.H., Barker G.F., Golub T.R., Gilliland D.G. The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14845-14850
-
(1996)
Proc. Natl. Acad. Sci. U.S.A.
, vol.93
, pp. 14845-14850
-
-
Carroll, M.1
Tomasson, M.H.2
Barker, G.F.3
Golub, T.R.4
Gilliland, D.G.5
-
25
-
-
17144463437
-
A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein
-
Jousset C., Carron C., Boureux A., Quang C.T., Oury C., Dusanter-Fourt I., et al. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein. EMBO J. 16:1997;69-82
-
(1997)
EMBO J.
, vol.16
, pp. 69-82
-
-
Jousset, C.1
Carron, C.2
Boureux, A.3
Quang, C.T.4
Oury, C.5
Dusanter-Fourt, I.6
-
26
-
-
0033604460
-
Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein
-
Sjöblom T., Boureux A., Rönnstrand L., Heldin C.-H., Ghysdael J., Östman A. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein. Oncogene. 18:1999;7055-7062
-
(1999)
Oncogene
, vol.18
, pp. 7055-7062
-
-
Sjöblom, T.1
Boureux, A.2
Rönnstrand, L.3
Heldin, C.-H.4
Ghysdael, J.5
Östman, A.6
-
27
-
-
0033084227
-
TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor
-
Tomasson M.H., Williams I.R., Hasserjian R., Udomsakdi C., McGrath S.M., Schwaller J., et al. TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood. 93:1999;1707-1714
-
(1999)
Blood
, vol.93
, pp. 1707-1714
-
-
Tomasson, M.H.1
Williams, I.R.2
Hasserjian, R.3
Udomsakdi, C.4
McGrath, S.M.5
Schwaller, J.6
-
28
-
-
0033999917
-
Fatal myeloproliferation induced in mice by TEL/PDGFbetaR expression depends on PDGFbetaR tyrosines 579/581
-
Tomasson M.H., Sternberg D.W., Williams I.R., Carroll M., Cain D., Aster J.C., et al. Fatal myeloproliferation induced in mice by TEL/PDGFbetaR expression depends on PDGFbetaR tyrosines 579/581. J. Clin. Invest. 105:2000;423-432
-
(2000)
J. Clin. Invest.
, vol.105
, pp. 423-432
-
-
Tomasson, M.H.1
Sternberg, D.W.2
Williams, I.R.3
Carroll, M.4
Cain, D.5
Aster, J.C.6
-
29
-
-
0030669455
-
Fusion of the platelet-derived growth factor receptor β to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution
-
Abe A., Emi N., Tanimoto M., Terasaki H., Marunouchi T., Saito H. Fusion of the platelet-derived growth factor receptor β to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood. 90:1997;4271-4277
-
(1997)
Blood
, vol.90
, pp. 4271-4277
-
-
Abe, A.1
Emi, N.2
Tanimoto, M.3
Terasaki, H.4
Marunouchi, T.5
Saito, H.6
-
30
-
-
0035889128
-
Rabaptin-5 is a novel fusion partner to platelet-derived growth factor β receptor in chronic myelomonocytic leukemia
-
Magnusson M.K., Meade K.E., Brown K.E., Arthur D.C., Krueger L.A., Barrett A.J., et al. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor β receptor in chronic myelomonocytic leukemia. Blood. 98:2001;2518-2525
-
(2001)
Blood
, vol.98
, pp. 2518-2525
-
-
Magnusson, M.K.1
Meade, K.E.2
Brown, K.E.3
Arthur, D.C.4
Krueger, L.A.5
Barrett, A.J.6
-
31
-
-
18344404198
-
Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)
-
Kulkarni S., Heath C., Parker S., Chase A., Iqbal S., Pocock C.F., et al. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21). Cancer Res. 60:2000;3592-3598
-
(2000)
Cancer Res.
, vol.60
, pp. 3592-3598
-
-
Kulkarni, S.1
Heath, C.2
Parker, S.3
Chase, A.4
Iqbal, S.5
Pocock, C.F.6
-
32
-
-
0031864246
-
Fusion of Huntington interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)
-
Ross T.S., Bernard O.A., Berger R., Gilliland D.G. Fusion of Huntington interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood. 91:1998;4419-4426
-
(1998)
Blood
, vol.91
, pp. 4419-4426
-
-
Ross, T.S.1
Bernard, O.A.2
Berger, R.3
Gilliland, D.G.4
-
33
-
-
0346186282
-
Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders
-
Baxter E.J., Kulkarni S., Vizmanos J.L., Jaju R., Martinelli G., Testoni N., et al. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders. Br. J. Haematol. 120:2003;251-256
-
(2003)
Br. J. Haematol.
, vol.120
, pp. 251-256
-
-
Baxter, E.J.1
Kulkarni, S.2
Vizmanos, J.L.3
Jaju, R.4
Martinelli, G.5
Testoni, N.6
-
34
-
-
70350186921
-
The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA
-
Baxter E.J., Hochhaus A., Bolufer P., Reiter A., Fernandez J.M., Senent L., et al. The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA. Hum. Mol. Genet. 11:2002;1391-1397
-
(2002)
Hum. Mol. Genet.
, vol.11
, pp. 1391-1397
-
-
Baxter, E.J.1
Hochhaus, A.2
Bolufer, P.3
Reiter, A.4
Fernandez, J.M.5
Senent, L.6
-
35
-
-
0041335547
-
Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: A new clinical target for STI571/Glivec
-
Trempat P., Villalva C., Laurent G., Armstrong F., Delsol G., Dastugue N., et al. Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec. Oncogene. 22:2003;5702-5706
-
(2003)
Oncogene
, vol.22
, pp. 5702-5706
-
-
Trempat, P.1
Villalva, C.2
Laurent, G.3
Armstrong, F.4
Delsol, G.5
Dastugue, N.6
-
36
-
-
1842474941
-
The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: Implications for diagnosis, classification, and management
-
doi: 10.1182/blood-2003-06-1824
-
Gotlib J, Cools J, Malone JM, Schrier SL, Gilliland DG, Coutre SE. The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2003. doi: 10.1182/blood-2003-06-1824
-
(2003)
Blood
-
-
Gotlib, J.1
Cools, J.2
Malone, J.M.3
Schrier, S.L.4
Gilliland, D.G.5
Coutre, S.E.6
-
37
-
-
0344987881
-
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
-
Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med. 348:2003;1201-1214
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1201-1214
-
-
Cools, J.1
Deangelo, D.J.2
Gotlib, J.3
Stover, E.H.4
Legare, R.D.5
Cortes, J.6
-
38
-
-
0037596569
-
Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome
-
Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc. Natl. Acad. Sci. U.S.A. 100:2003;7830-7835
-
(2003)
Proc. Natl. Acad. Sci. U.S.A.
, vol.100
, pp. 7830-7835
-
-
Griffin, J.H.1
Leung, J.2
Bruner, R.J.3
Caligiuri, M.A.4
Briesewitz, R.5
-
39
-
-
10744228486
-
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
-
Pardanani A., Ketterling R.P., Brockman S.R., Flynn H.C., Paternoster S.F., Shearer B.M., et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood. 102:2003;3093-3096
-
(2003)
Blood
, vol.102
, pp. 3093-3096
-
-
Pardanani, A.1
Ketterling, R.P.2
Brockman, S.R.3
Flynn, H.C.4
Paternoster, S.F.5
Shearer, B.M.6
-
40
-
-
0038386031
-
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
-
Pardanani A., Reeder T., Porrata L.F., Li C.Y., Tazelaar H.D., Baxter E.J., et al. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood. 101:2003;3391-3397
-
(2003)
Blood
, vol.101
, pp. 3391-3397
-
-
Pardanani, A.1
Reeder, T.2
Porrata, L.F.3
Li, C.Y.4
Tazelaar, H.D.5
Baxter, E.J.6
-
41
-
-
1642324059
-
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA positive chronic eosinophilic leukemia
-
Cools J., Quentmeier H., Huntly B.J., Marynen P., Griffin J.D., Drexler H.G., et al. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA positive chronic eosinophilic leukemia. Blood. 103:2004;2802-2805
-
(2004)
Blood
, vol.103
, pp. 2802-2805
-
-
Cools, J.1
Quentmeier, H.2
Huntly, B.J.3
Marynen, P.4
Griffin, J.D.5
Drexler, H.G.6
-
42
-
-
0034659906
-
World Health Organization classification of tumors
-
Kleihues P., Sobin L.H. World Health Organization classification of tumors. Cancer. 88:2000;2887
-
(2000)
Cancer
, vol.88
, pp. 2887
-
-
Kleihues, P.1
Sobin, L.H.2
-
43
-
-
0034987702
-
Malignant glioma: Genetics and biology of a grave matter
-
Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15:2001;1311-1333
-
(2001)
Genes Dev.
, vol.15
, pp. 1311-1333
-
-
Maher, E.A.1
Furnari, F.B.2
Bachoo, R.M.3
Rowitch, D.H.4
Louis, D.N.5
Cavenee, W.K.6
-
44
-
-
0026772431
-
Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
-
Hermanson M., Funa K., Hartman M., Claesson-Welsh L., Heldin C.-H., Westermark B., et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 52:1992;3213-3219
-
(1992)
Cancer Res.
, vol.52
, pp. 3213-3219
-
-
Hermanson, M.1
Funa, K.2
Hartman, M.3
Claesson-Welsh, L.4
Heldin, C.-H.5
Westermark, B.6
-
45
-
-
9044248587
-
Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas
-
Hermanson M., Funa K., Koopmann J., Maintz D., Waha A., Westermark B., et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas. Cancer Res. 56:1996;164-171
-
(1996)
Cancer Res.
, vol.56
, pp. 164-171
-
-
Hermanson, M.1
Funa, K.2
Koopmann, J.3
Maintz, D.4
Waha, A.5
Westermark, B.6
-
46
-
-
0026793260
-
Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors
-
Fleming T.P., Saxena A., Clark W.C., Robertson J.T., Oldfield E.H., Aaronson S.A., et al. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res. 52:1992;4550-4553
-
(1992)
Cancer Res.
, vol.52
, pp. 4550-4553
-
-
Fleming, T.P.1
Saxena, A.2
Clark, W.C.3
Robertson, J.T.4
Oldfield, E.H.5
Aaronson, S.A.6
-
47
-
-
0026600613
-
Amplification of α-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin
-
Kumabe T., Sohma Y., Kayama T., Yoshimoto T., Yamamoto T. Amplification of α-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene. 7:1992;627-633
-
(1992)
Oncogene
, vol.7
, pp. 627-633
-
-
Kumabe, T.1
Sohma, Y.2
Kayama, T.3
Yoshimoto, T.4
Yamamoto, T.5
-
48
-
-
0037421971
-
A human brain tumor-derived PDGFR-alpha deletion mutant is transforming
-
Clarke I.D., Dirks P.B. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming. Oncogene. 22:2003;722-733
-
(2003)
Oncogene
, vol.22
, pp. 722-733
-
-
Clarke, I.D.1
Dirks, P.B.2
-
49
-
-
0001288041
-
The biology of primate retrovirus
-
Klein G. (Ed.), New York: Raven;
-
Deinhardt F. The biology of primate retrovirus. In: Klein G. (Ed.), Viral oncology. New York: Raven; 1980. p. 359-398.
-
(1980)
Viral Oncology
, pp. 359-398
-
-
Deinhardt, F.1
-
50
-
-
0032401819
-
Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus
-
Uhrbom L., Hesselager G., Nistér M., Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 58:1998;5275-5279
-
(1998)
Cancer Res.
, vol.58
, pp. 5275-5279
-
-
Uhrbom, L.1
Hesselager, G.2
Nistér, M.3
Westermark, B.4
-
51
-
-
0035425048
-
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
-
Dai C., Celestino J.C., Okada Y., Louis D.N., Fuller G.N., Holland E.C. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15:2001;1913-1925
-
(2001)
Genes Dev.
, vol.15
, pp. 1913-1925
-
-
Dai, C.1
Celestino, J.C.2
Okada, Y.3
Louis, D.N.4
Fuller, G.N.5
Holland, E.C.6
-
52
-
-
0042591478
-
Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model
-
Hesselager G., Uhrbom L., Westermark B., Nister M. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res. 63:2003;4305-4309
-
(2003)
Cancer Res.
, vol.63
, pp. 4305-4309
-
-
Hesselager, G.1
Uhrbom, L.2
Westermark, B.3
Nister, M.4
-
53
-
-
0027361809
-
Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells
-
Shamah S.M., Stiles C.D., Guha A. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol. Cell. Biol. 13:1993;7203-7212
-
(1993)
Mol. Cell. Biol.
, vol.13
, pp. 7203-7212
-
-
Shamah, S.M.1
Stiles, C.D.2
Guha, A.3
-
54
-
-
0027980975
-
Inhibition of glioma cell growth by a truncated platelet-derived growth factor-b receptor
-
Strawn L.M., Mann E., Elliger S.S., Chu L.M., Germain L.L., Niederfellner G., et al. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-b receptor. J. Biol. Chem. 269:1994;21215-21222
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 21215-21222
-
-
Strawn, L.M.1
Mann, E.2
Elliger, S.S.3
Chu, L.M.4
Germain, L.L.5
Niederfellner, G.6
-
55
-
-
0034665138
-
Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class
-
Kilic T., Alberta J.A., Zdunek P.R., Acar M., Iannarelli P., O'Reilly T., et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res. 60:2000;5143-5150
-
(2000)
Cancer Res.
, vol.60
, pp. 5143-5150
-
-
Kilic, T.1
Alberta, J.A.2
Zdunek, P.R.3
Acar, M.4
Iannarelli, P.5
O'Reilly, T.6
-
56
-
-
0024523834
-
Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene
-
Pech M., Gazit A., Arnstein P., Aaronson S.A. Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2693-2697
-
(1989)
Proc. Natl. Acad. Sci. U.S.A.
, vol.86
, pp. 2693-2697
-
-
Pech, M.1
Gazit, A.2
Arnstein, P.3
Aaronson, S.A.4
-
57
-
-
0026581358
-
Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin
-
Smits A., Funa K., Vassbotn F.S., Beausang-Linder M., af Ekenstam F., Heldin C.-H., et al. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. Am. J. Pathol. 140:1992;639-648
-
(1992)
Am. J. Pathol.
, vol.140
, pp. 639-648
-
-
Smits, A.1
Funa, K.2
Vassbotn, F.S.3
Beausang-Linder, M.4
Af Ekenstam, F.5
Heldin, C.-H.6
-
58
-
-
0028012103
-
Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: An immunohistochemical and in situ hybridization study
-
Wang J., Coltrera M.D., Gown A.M. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. Cancer Res. 54:1994;560-564
-
(1994)
Cancer Res.
, vol.54
, pp. 560-564
-
-
Wang, J.1
Coltrera, M.D.2
Gown, A.M.3
-
59
-
-
0030699247
-
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
-
Lee S.B., Kolquist K.A., Nichols K., Englert C., Maheswaran S., Ladanyi M., et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat. Genet. 17:1997;309-313
-
(1997)
Nat. Genet.
, vol.17
, pp. 309-313
-
-
Lee, S.B.1
Kolquist, K.A.2
Nichols, K.3
Englert, C.4
Maheswaran, S.5
Ladanyi, M.6
-
60
-
-
0035242001
-
PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
-
Zwerner J.P., May W.A. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene. 20:2001;626-633
-
(2001)
Oncogene
, vol.20
, pp. 626-633
-
-
Zwerner, J.P.1
May, W.A.2
-
61
-
-
0037198637
-
Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines
-
Zwerner J.P., May W.A. Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines. Oncogene. 21:2002;3847-3854
-
(2002)
Oncogene
, vol.21
, pp. 3847-3854
-
-
Zwerner, J.P.1
May, W.A.2
-
62
-
-
0032875460
-
Mechanism of action and in vivo role of platelet-derived growth factor
-
Heldin C.-H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79:1999;1283-1316
-
(1999)
Physiol. Rev.
, vol.79
, pp. 1283-1316
-
-
Heldin, C.-H.1
Westermark, B.2
-
63
-
-
0038670241
-
Mutational analysis of the tyrosine kinome in colorectal cancers
-
Bardelli A., Parsons D.W., Silliman N., Ptak J., Szabo S., Saha S., et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science. 300:2003;949
-
(2003)
Science
, vol.300
, pp. 949
-
-
Bardelli, A.1
Parsons, D.W.2
Silliman, N.3
Ptak, J.4
Szabo, S.5
Saha, S.6
-
64
-
-
0035979147
-
A role of PDGFRα in basal cell carcinoma proliferation
-
Xie J., Aszterbaum M., Zhang X., Bonifas J.M., Zachary C., Epstein E., et al. A role of PDGFRα in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9255-9259
-
(2001)
Proc. Natl. Acad. Sci. U.S.A.
, vol.98
, pp. 9255-9259
-
-
Xie, J.1
Aszterbaum, M.2
Zhang, X.3
Bonifas, J.M.4
Zachary, C.5
Epstein, E.6
-
65
-
-
0036793520
-
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ Receptors
-
Cao R., Bråkenhielm E., Li X., Pietras K., Widenfalk J., Östman A., et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ receptors. FASEB J. 16:2002;1575-1583
-
(2002)
FASEB J.
, vol.16
, pp. 1575-1583
-
-
Cao, R.1
Bråkenhielm, E.2
Li, X.3
Pietras, K.4
Widenfalk, J.5
Östman, A.6
-
66
-
-
0027082937
-
Platelet-derived growth factor is angiogenic in vivo
-
Risau W., Drexler H., Mironov V., Smits A., Siegbahn A., Funa K., et al. Platelet-derived growth factor is angiogenic in vivo. Growth Factors. 7:1992;261-266
-
(1992)
Growth Factors
, vol.7
, pp. 261-266
-
-
Risau, W.1
Drexler, H.2
Mironov, V.3
Smits, A.4
Siegbahn, A.5
Funa, K.6
-
67
-
-
0028557063
-
Three isoforms of platelet-derived growth factors all have the capability to induce angiogenesis in vivo
-
Oikawa T., Onozawa C., Sakaguchi M., Morita I., Murota S. Three isoforms of platelet-derived growth factors all have the capability to induce angiogenesis in vivo. Biol. Pharm. Bull. 17:1994;1686-1688
-
(1994)
Biol. Pharm. Bull.
, vol.17
, pp. 1686-1688
-
-
Oikawa, T.1
Onozawa, C.2
Sakaguchi, M.3
Morita, I.4
Murota, S.5
-
68
-
-
10744227995
-
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases
-
Uehara H., Kim S.J., Karashima T., Shepherd D.L., Fan D., Tsan R., et al. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J. Natl. Cancer Inst. 95:2003;458-470
-
(2003)
J. Natl. Cancer Inst.
, vol.95
, pp. 458-470
-
-
Uehara, H.1
Kim, S.J.2
Karashima, T.3
Shepherd, D.L.4
Fan, D.5
Tsan, R.6
-
69
-
-
0345798150
-
Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors
-
Abramsson A., Lindblom P., Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112:2003;1142-1151
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 1142-1151
-
-
Abramsson, A.1
Lindblom, P.2
Betsholtz, C.3
-
70
-
-
0346333243
-
Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model
-
Hwang R.F., Yokoi K., Bucana C.D., Tsan R., Killion J.J., Evans D.B., et al. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin. Cancer Res. 9:2003;6534-6544
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 6534-6544
-
-
Hwang, R.F.1
Yokoi, K.2
Bucana, C.D.3
Tsan, R.4
Killion, J.J.5
Evans, D.B.6
-
71
-
-
0038476608
-
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
-
Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111:2003;1287-1295
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 1287-1295
-
-
Bergers, G.1
Song, S.2
Meyer-Morse, N.3
Bergsland, E.4
Hanahan, D.5
-
72
-
-
0344837389
-
Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment
-
Guo P., Hu B., Gu W., Xu L., Wang D., Huang H.J., et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am. J. Pathol. 162:2003;1083-1093
-
(2003)
Am. J. Pathol.
, vol.162
, pp. 1083-1093
-
-
Guo, P.1
Hu, B.2
Gu, W.3
Xu, L.4
Wang, D.5
Huang, H.J.6
-
73
-
-
1442290142
-
Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms
-
Erber R., Thurnher A., Katsen A.D., Groth G., Kerger H., Hammes H.P., et al. Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J. 18:2004;338-340
-
(2004)
FASEB J.
, vol.18
, pp. 338-340
-
-
Erber, R.1
Thurnher, A.2
Katsen, A.D.3
Groth, G.4
Kerger, H.5
Hammes, H.P.6
-
74
-
-
84862432400
-
PDGF production by B16 melanoma cells leads to increased pericyte coverage of vessels and an associated increase in tumor growth rate
-
in press.
-
Furuhashi M, Sjöblom T, Abramsson A., Ellingsen J, Micke P, Li H, et al. PDGF production by B16 melanoma cells leads to increased pericyte coverage of vessels and an associated increase in tumor growth rate. Cancer Res, in press.
-
Cancer Res
-
-
Furuhashi, M.1
Sjöblom, T.2
Abramsson, A.3
Ellingsen, J.4
Micke, P.5
Li, H.6
-
75
-
-
0036140857
-
Analysis of mural cell recruitment to tumor vessels
-
Abramsson A., Berlin O., Papayan H., Paulin D., Shani M., Betsholtz C. Analysis of mural cell recruitment to tumor vessels. Circulation. 105:2002;112-117
-
(2002)
Circulation
, vol.105
, pp. 112-117
-
-
Abramsson, A.1
Berlin, O.2
Papayan, H.3
Paulin, D.4
Shani, M.5
Betsholtz, C.6
-
76
-
-
0036124520
-
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
-
Morikawa S., Baluk P., Kaidoh T., Haskell A., Jain R.K., McDonald D.M. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160:2002;985-1000
-
(2002)
Am. J. Pathol.
, vol.160
, pp. 985-1000
-
-
Morikawa, S.1
Baluk, P.2
Kaidoh, T.3
Haskell, A.4
Jain, R.K.5
McDonald, D.M.6
-
77
-
-
1042301958
-
Targeting the platelet-derived growth factor in antivascular therapy for human ovarian carcinoma
-
Apte S.M., Fan D., Killion J.J., Fidler I.J. Targeting the platelet-derived growth factor in antivascular therapy for human ovarian carcinoma. Clin. Cancer Res. 10:2004;807-908
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 807-908
-
-
Apte, S.M.1
Fan, D.2
Killion, J.J.3
Fidler, I.J.4
-
78
-
-
0027744498
-
Microvascular pericytes express platelet-derived growth factor-β receptors in human healing wounds and colorectal adenocarcinoma
-
Sundberg C., Ljungström M., Lindmark G., Gerdin B., Rubin K. Microvascular pericytes express platelet-derived growth factor-β receptors in human healing wounds and colorectal adenocarcinoma. Am. J. Pathol. 143:1993;1377-1388
-
(1993)
Am. J. Pathol.
, vol.143
, pp. 1377-1388
-
-
Sundberg, C.1
Ljungström, M.2
Lindmark, G.3
Gerdin, B.4
Rubin, K.5
-
79
-
-
0037967272
-
Tumorigenesis and the angiogenic switch
-
Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer. 3:2003;401-410
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 401-410
-
-
Bergers, G.1
Benjamin, L.E.2
-
80
-
-
0033617532
-
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
-
Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812
-
(1999)
Science
, vol.284
, pp. 808-812
-
-
Bergers, G.1
Javaherian, K.2
Lo, K.M.3
Folkman, J.4
Hanahan, D.5
-
81
-
-
0026439870
-
Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas
-
Plate K.H., Breier G., Farrell C.L., Risau W. Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest. 67:1992;529-534
-
(1992)
Lab. Invest.
, vol.67
, pp. 529-534
-
-
Plate, K.H.1
Breier, G.2
Farrell, C.L.3
Risau, W.4
-
82
-
-
0008887031
-
Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation
-
Hermanson M., Nistér M., Betsholtz C., Heldin C.-H., Westermark B., Funa K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7748-7752
-
(1988)
Proc. Natl. Acad. Sci. U.S.A.
, vol.85
, pp. 7748-7752
-
-
Hermanson, M.1
Nistér, M.2
Betsholtz, C.3
Heldin, C.-H.4
Westermark, B.5
Funa, K.6
-
83
-
-
0028280287
-
Epithelial-stromal interactions in basal cell cancer: The PDGF system
-
Pontén F., Ren Z., Nistér M., Westermark B., Pontén J. Epithelial-stromal interactions in basal cell cancer: the PDGF system. J. Invest. Dermatol. 102:1994;304-309
-
(1994)
J. Invest. Dermatol.
, vol.102
, pp. 304-309
-
-
Pontén, F.1
Ren, Z.2
Nistér, M.3
Westermark, B.4
Pontén, J.5
-
84
-
-
0029978211
-
Localization of platelet-derived growth factor β receptor expression in the periepithelial stroma of human breast carcinoma
-
Bhardwaj B., Klassen J., Cossette N., Sterns E., Tuck A., Deeley R., et al. Localization of platelet-derived growth factor β receptor expression in the periepithelial stroma of human breast carcinoma. Clin. Cancer Res. 2:1996;773-782
-
(1996)
Clin. Cancer Res.
, vol.2
, pp. 773-782
-
-
Bhardwaj, B.1
Klassen, J.2
Cossette, N.3
Sterns, E.4
Tuck, A.5
Deeley, R.6
-
85
-
-
0027723524
-
Stromal expression of platelet-derived growth factor β-receptor and platelet-derived growth factor B-chain in colorectal cancer
-
Lindmark G., Sundberg C., Glimelius B., Påhlman L., Rubin K., Gerdin B. Stromal expression of platelet-derived growth factor β-receptor and platelet-derived growth factor B-chain in colorectal cancer. Lab. Invest. 69:1993;682-689
-
(1993)
Lab. Invest.
, vol.69
, pp. 682-689
-
-
Lindmark, G.1
Sundberg, C.2
Glimelius, B.3
Påhlman, L.4
Rubin, K.5
Gerdin, B.6
-
86
-
-
0030725954
-
Expression in lung carcinomas of platelet-derived growth factor and its receptors
-
Kawai T., Hiroi S., Torikata C. Expression in lung carcinomas of platelet-derived growth factor and its receptors. Lab. Invest. 77:1997;431-436
-
(1997)
Lab. Invest.
, vol.77
, pp. 431-436
-
-
Kawai, T.1
Hiroi, S.2
Torikata, C.3
-
87
-
-
0025019999
-
Expression of platelet-derived growth factor β-receptors on stromal tissue cells in human carcinoid tumors
-
Funa K., Papanicolaou V., Juhlin C., Rastad J., Åkerström G., Heldin C.H., et al. Expression of platelet-derived growth factor β-receptors on stromal tissue cells in human carcinoid tumors. Cancer Res. 50:1990;748-753
-
(1990)
Cancer Res.
, vol.50
, pp. 748-753
-
-
Funa, K.1
Papanicolaou, V.2
Juhlin, C.3
Rastad, J.4
Åkerström, G.5
Heldin, C.H.6
-
88
-
-
0029146793
-
Induction of platelet-derived growth factor a and B chains and over-expression of their receptors in human pancreatic cancer
-
Ebert M., Yokoyama M., Friess H., Kobrin M.S., Büchler M.W., Korc M. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int. J. Cancer. 62:1995;529-535
-
(1995)
Int. J. Cancer
, vol.62
, pp. 529-535
-
-
Ebert, M.1
Yokoyama, M.2
Friess, H.3
Kobrin, M.S.4
Büchler, M.W.5
Korc, M.6
-
89
-
-
0037389850
-
Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors
-
Fjällskog M.L., Lejonklou M.H., Öberg K.E., Eriksson B.K., Janson E.T. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin. Cancer Res. 9:2003;1469-1473
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 1469-1473
-
-
Fjällskog, M.L.1
Lejonklou, M.H.2
Öberg, K.E.3
Eriksson, B.K.4
Janson, E.T.5
-
90
-
-
0027397240
-
Platelet-derived growth factor (PDGF) in oncogenesis: Development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB
-
Forsberg K., Valyi-Nagy I., Heldin C.-H., Herlyn M., Westermark B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl. Acad. Sci. U.S.A. 90:1993;393-397
-
(1993)
Proc. Natl. Acad. Sci. U.S.A.
, vol.90
, pp. 393-397
-
-
Forsberg, K.1
Valyi-Nagy, I.2
Heldin, C.-H.3
Herlyn, M.4
Westermark, B.5
-
91
-
-
0032477806
-
Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
-
Skobe M., Fusenig N.E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1050-1055
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 1050-1055
-
-
Skobe, M.1
Fusenig, N.E.2
-
92
-
-
0034618408
-
Human breast carcinoma desmoplasia is PDGF initiated
-
Shao Z.M., Nguyen M., Barsky S.H. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene. 19:2000;4337-4345
-
(2000)
Oncogene
, vol.19
, pp. 4337-4345
-
-
Shao, Z.M.1
Nguyen, M.2
Barsky, S.H.3
-
93
-
-
0035291243
-
Delivery of molecular and cellular medicine to solid tumors
-
Jain R.K. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 46:2001;149-168
-
(2001)
Adv. Drug Deliv. Rev.
, vol.46
, pp. 149-168
-
-
Jain, R.K.1
-
94
-
-
0035297541
-
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors
-
Pietras K., Östman A., Sjöquist M., Buchdunger E., Reed R.K., Heldin C.H., et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 61:2001;2929-2934
-
(2001)
Cancer Res.
, vol.61
, pp. 2929-2934
-
-
Pietras, K.1
Östman, A.2
Sjöquist, M.3
Buchdunger, E.4
Reed, R.K.5
Heldin, C.H.6
-
95
-
-
0036790060
-
Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy
-
Pietras K., Rubin K., Sjöblom T., Buchdunger E., Sjöquist M., Heldin C.-H., et al. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res. 62:2002;5476-5484
-
(2002)
Cancer Res.
, vol.62
, pp. 5476-5484
-
-
Pietras, K.1
Rubin, K.2
Sjöblom, T.3
Buchdunger, E.4
Sjöquist, M.5
Heldin, C.-H.6
-
96
-
-
0141567995
-
STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake
-
Pietras K., Stumm M., Hubert M., Buchdunger E., Rubin K., Heldin C.-H., et al. STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake. Clin. Cancer Res. 9:2003;3779-3787
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 3779-3787
-
-
Pietras, K.1
Stumm, M.2
Hubert, M.3
Buchdunger, E.4
Rubin, K.5
Heldin, C.-H.6
-
97
-
-
0037143794
-
Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans
-
Maki R.G., Awan R.A., Dixon R.H., Jhanwar S., Antonescu C.R. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int. J. Cancer. 100:2002;623-626
-
(2002)
Int. J. Cancer
, vol.100
, pp. 623-626
-
-
Maki, R.G.1
Awan, R.A.2
Dixon, R.H.3
Jhanwar, S.4
Antonescu, C.R.5
-
98
-
-
0036727124
-
Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans
-
Rubin B.P., Schuetze S.M., Eary J.F., Norwood T.H., Mirza S., Conrad E.U., et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J. Clin. Oncol. 20:2002;3586-3591
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 3586-3591
-
-
Rubin, B.P.1
Schuetze, S.M.2
Eary, J.F.3
Norwood, T.H.4
Mirza, S.5
Conrad, E.U.6
-
99
-
-
0038388677
-
Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: A new case report
-
Pitini V., Arrigo C., Teti D., Barresi G., Righi M., Alo G. Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report. Haematologica. 88:2003;ECR18
-
(2003)
Haematologica
, vol.88
, pp. 18
-
-
Pitini, V.1
Arrigo, C.2
Teti, D.3
Barresi, G.4
Righi, M.5
Alo, G.6
-
100
-
-
0141816686
-
Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta
-
Garcia J.L., Font de Mora J., Hernandez J.M., Queizan J.A., Gutierrez N.C., San Miguel J.F. Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta. Blood. 102:2003;2699-2700
-
(2003)
Blood
, vol.102
, pp. 2699-2700
-
-
Garcia, J.L.1
Font De Mora, J.2
Hernandez, J.M.3
Queizan, J.A.4
Gutierrez, N.C.5
San Miguel, J.F.6
-
101
-
-
0037103624
-
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
-
Apperley J.F., Gardembas M., Melo J.V., Russell-Jones R., Bain B.J., Baxter E.J. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N. Engl. J. Med. 347:2002;481-487
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 481-487
-
-
Apperley, J.F.1
Gardembas, M.2
Melo, J.V.3
Russell-Jones, R.4
Bain, B.J.5
Baxter, E.J.6
-
102
-
-
0036682958
-
Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor β receptor fusion oncogene
-
Magnusson M.K., Meade K.E., Nakamura R., Barrett J., Dunbar C.E. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor β receptor fusion oncogene. Blood. 100:2002;1088-1091
-
(2002)
Blood
, vol.100
, pp. 1088-1091
-
-
Magnusson, M.K.1
Meade, K.E.2
Nakamura, R.3
Barrett, J.4
Dunbar, C.E.5
-
103
-
-
0942276859
-
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome
-
Klion A.D., Robyn J., Akin C., Noel P., Brown M., Law M., et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood. 103:2004;473-478
-
(2004)
Blood
, vol.103
, pp. 473-478
-
-
Klion, A.D.1
Robyn, J.2
Akin, C.3
Noel, P.4
Brown, M.5
Law, M.6
-
104
-
-
0345688603
-
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
-
Shah N.P., Sawyers C.L. Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias. Oncogene. 22:2003;7389-7395
-
(2003)
Oncogene
, vol.22
, pp. 7389-7395
-
-
Shah, N.P.1
Sawyers, C.L.2
-
105
-
-
0142119964
-
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease
-
Cools J., Stover E.H., Boulton C.L., Gotlib J., Legare R.D., Amaral S.M., et al. PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease. Cancer Cell. 3:2003;459-469
-
(2003)
Cancer Cell
, vol.3
, pp. 459-469
-
-
Cools, J.1
Stover, E.H.2
Boulton, C.L.3
Gotlib, J.4
Legare, R.D.5
Amaral, S.M.6
-
106
-
-
0033613119
-
Platelet-derived growth factor b receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling
-
Heuchel R., Berg A., Tallquist M., Åhlén K., Reed R.K., Rubin K., et al. Platelet-derived growth factor b receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11410-11415
-
(1999)
Proc. Natl. Acad. Sci. U.S.A.
, vol.96
, pp. 11410-11415
-
-
Heuchel, R.1
Berg, A.2
Tallquist, M.3
Åhlén, K.4
Reed, R.K.5
Rubin, K.6
-
107
-
-
1042301962
-
Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma
-
Tamborini E., Bonadiman L., Greco A., Gronchi A., Riva C., Bertulli R., et al. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma. Clin. Cancer Res. 10:2004;938-943
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 938-943
-
-
Tamborini, E.1
Bonadiman, L.2
Greco, A.3
Gronchi, A.4
Riva, C.5
Bertulli, R.6
-
108
-
-
0842311601
-
Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and akt inactivation
-
Matei D., Chang D.D., Jeng M.-H. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and akt inactivation. Clin. Cancer Res. 10:2004;681-690
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 681-690
-
-
Matei, D.1
Chang, D.D.2
Jeng, M.-H.3
-
109
-
-
1642336256
-
A potential oncogenic activity of platelet-derived growth factor D in prostate cancer progression
-
Ustach C.V., Taube M.E., Hurst N.J. Jr., Bhagat S., Bonfil R.D., Cher M.L., et al. A potential oncogenic activity of platelet-derived growth factor D in prostate cancer progression. Cancer Res. 64:2004;1722-1729
-
(2004)
Cancer Res.
, vol.64
, pp. 1722-1729
-
-
Ustach, C.V.1
Taube, M.E.2
Hurst Jr., N.J.3
Bhagat, S.4
Bonfil, R.D.5
Cher, M.L.6
-
110
-
-
0842323936
-
Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression
-
Beppu K., Jaboine J., Merchant M.S., Mackall C.L., Thiele C.J. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J. Natl. Cancer Inst. 96:2004;46-55
-
(2004)
J. Natl. Cancer Inst.
, vol.96
, pp. 46-55
-
-
Beppu, K.1
Jaboine, J.2
Merchant, M.S.3
MacKall, C.L.4
Thiele, C.J.5
|